Ofatumumab for the treatment of refractory anti‐LGI1 encephalitis with long‐term poor blood glucose control in type 1 diabetes

Detalles Bibliográficos
Autores principales: Chen, Kaili, Yang, Le, Xu, Lei, Jiang, Yan, He, Jinting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651958/
https://www.ncbi.nlm.nih.gov/pubmed/37602875
http://dx.doi.org/10.1111/cns.14416

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10651958/
https://www.ncbi.nlm.nih.gov/pubmed/37602875
http://dx.doi.org/10.1111/cns.14416

Ejemplares similares